Geropharm - Crunchbase Company Profile & Funding

Q: Who invested in Geropharm?

Geropharm is funded by Russian Direct Investment Fund.

Q: When was the last funding round for Geropharm?

Geropharm closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Geropharm

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Geropharm

CB Rank

537659

Geropharm is a pharmaceutical company that provides the development and production of medicinal products for restoring brain function.

Founded

obfuscation

Private

Venture - Series Unknown

Saint Petersburg, Saint Petersburg City, Russian Federation

1001-5000

geropharm.com

Biopharma

Biotechnology

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Details

Operating Status

Active

Company Type

For Profit

About the Company

Geropharm is a biotechnological company that provides development, production, and investment for the creation of modern pharmaceutical infrastructure and medicinal products. The company provides molecule registration of the drug and development through the in-house research center.

Phone Number

+7 812-703-79-75

Contact Email

inform@geropharm.ru

Predictions & Insights

Growth Insight

See this Growth Insight

Geropharm is

Lorem

to be growing

Top Contributing Factors

Market Share Expansion

Growth Prediction

See this Growth Prediction

Products & Services

Rinsulin® NPH

A middle-term effect human insulin produced via recombinant DNA technology for subcutaneous administration to manage blood glucose levels in diabetes patients.

RinGlusin®

A rapid-acting insulin analogue with glulisine as the active substance, used for managing blood glucose levels in diabetes patients requiring fast insulin action.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Geropharm	1	obfuscated obfuscation	Russian Direct Investment Fund	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Russian Direct Investment Fund	Yes	Venture Round - Geropharm	Kirill Dmitriev
Russian Direct Investment Fund	Yes	Venture Round - Geropharm	Kirill Dmitriev
Russian Direct Investment Fund	Yes	Venture Round - Geropharm	Kirill Dmitriev
Russian Direct Investment Fund	Yes	Venture Round - Geropharm	Kirill Dmitriev
Russian Direct Investment Fund	Yes	Venture Round - Geropharm	Kirill Dmitriev